J & J says court finds Remicade patent invalid

(Reuters) - Johnson& Johnson said a U.S. court had held its patent for autoimmune drug Remicade invalid, ruling in favor of two companies seeking to bring a cheaper version of the blockbuster drug to market.

Source: Reuters: Health - August 17, 2016 Category: Consumer Health News Tags: healthNews Source Type: news